Form 8-K - Current report:
SEC Accession No. 0000950123-05-004889
Filing Date
2005-04-22
Accepted
2005-04-22 17:18:59
Documents
7
Period of Report
2005-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y08086e8vk.txt 8-K 11722
2 EX-10.1: EMPLOYMENT SEPARATION AGREEMENT AND RELEASE OF LEGAL RIGHTS y08086exv10w1.txt EX-10.1 16659
3 EX-10.2: EMPLOYMENT AGREEMENT y08086exv10w2.txt EX-10.2 46852
4 EX-99.1: PRESS RELEASE y08086exv99w1.txt EX-99.1 4388
5 EX-99.2: PRESS RELEASE y08086exv99w2.txt EX-99.2 11070
6 EX-99.3: PRESS RELEASE y08086exv99w3.txt EX-99.3 8080
7 EX-99.4: PRESS RELEASE y08086exv99w4.txt EX-99.4 9506
  Complete submission text file 0000950123-05-004889.txt   110094
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 05768190
SIC: 2835 In Vitro & In Vivo Diagnostic Substances